 "BASF and Sumitomo to develop in vitro system for chemical safety evaluation")
Sumitomo Chemical Co Ltd and BASF have agreed to collaborate on research into a more sustainable, in vitro system for chemical safety evaluation. Recent years have seen an increase in stringent regulations for registration of agricultural chemicals and pharmaceuticals, and the demand to increase human relevance of safety studies. For these reasons, Sumitomo Chemical and BASF aim to create a system that supports the development of safe chemicals, while reducing the need for conventional animal testing.
As the first step in their research, Sumitomo Chemical and BASF aim to establish a new line of fully functional cultured cells to enable the safety evaluation of chemicals in a more efficient and more precise way than conventional methods.
Dr Peter Eckes, president of BASF bioscience research, said, “BASF celebrates its 150th anniversary this year, and we have a history of continuous commitment to sustainability throughout our operations. In this collaboration we are combining the strength of both companies to develop new methods to reduce animal testing.”
Ikuzo Ogawa, managing executive officer of Sumitomo Chemical in charge of technology and research & development, added, “We will contribute to building a sustainable society through supplying safer chemicals. We are very delighted to work on the collaborative research of such great social significance in the year marking the 100th anniversary of the start of Sumitomo Chemical’s operations.”
As the first step in their research, Sumitomo Chemical and BASF aim to establish a new line of fully functional cultured cells to enable the safety evaluation of chemicals in a more efficient and more precise way than conventional methods.
Dr Peter Eckes, president of BASF bioscience research, said, “BASF celebrates its 150th anniversary this year, and we have a history of continuous commitment to sustainability throughout our operations. In this collaboration we are combining the strength of both companies to develop new methods to reduce animal testing.”
Ikuzo Ogawa, managing executive officer of Sumitomo Chemical in charge of technology and research & development, added, “We will contribute to building a sustainable society through supplying safer chemicals. We are very delighted to work on the collaborative research of such great social significance in the year marking the 100th anniversary of the start of Sumitomo Chemical’s operations.”
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%